Newly approved vaccines receive recommendations from the Advisory Committee on Immunization Practices (ACIP).

In the last few months, three new vaccines have received approval from the FDA:  meningococcal B [Trumenba (Pfizer) and Bexsero (Novartis)] and HPV [Gardasil 9 (Merck)].  The ACIP met in late February to discuss these vaccines and their recommendations to the CDC for potential incorporation into the current immunization schedule.  Here is a summary of the committee’s recommendations.